Translational Digital Biomarkers
Webinars and Presentations

NA3RsC has organized a number of presentations about translational digital biomarkers. You can find out about upcoming presentations as well as view PDFs and/or recordings of previous presentations below.

Upcoming Presentations

  • TDB Webinar Series Part 3: Study Design, Date TBD

Translational Digital Biomarkers in Drug Discovery and Development Webinar Series

In 2022, the North American 3Rs Collaborative (NA3RsC) organized a 4-part webinar series, where experts from the  Translational Digital Biomarkers initiative  discussed the evidence, impact, and practical use of these technologies that provide novel insights for drug discovery and development (DDD).

1. Introduction, Opportunities, Challenges, & Implementation Overview

On May 4th, 2022 the NA3RsC organized the first webinar in our series. We introduced the initiative’s development and an overview of our recent publication titled “Emerging Role of Translational Digital Biomarkers Within Home Cage Monitoring Technologies in Preclinical Drug Discovery and Development.” We provided an overview of where digital biomarkers fit within DDD, consensus definitions of home cage monitoring, and digital biomarkers (DB) specifically for laboratory rodents. Presenters spoke to opportunities & challenges that the different DB technologies bring along with the data (from security to data analysis). Ultimately, both end-users and tech providers’ gave perspectives on critical points for a successful implementation. 

2. Realities of Onboarding Translational Digital Biomarker Technologies

On August 31, 2022 the NA3RsC organized the second webinar in our series. TDB experts Matt Ruiter, Paul Makidon, and Ellie Karlsson discussed key logistical & operations-related factors to implementing these novel technologies in the vivarium. They also discussed the roles of various personnel and ethical obligations with this technology.